09/03/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/3/2020. This four-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the cobas SARS-CoV-2 & Influenza A/B assay. Testing is to be conducted on specimens from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider. (PDF)
09/03/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/3/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the SGTi-flex COVID-19 IgG. The SGTi-flex COVID-19 IgG is authorized for the detection of IgG antibodies to SARS-CoV-2 in human serum, venous whole blood (sodium heparin, lithium heparin, sodium citrate and tripotassium EDTA), andplasma (sodium heparin, lithium heparin, sodium citrate and tripotassium EDTA). (PDF)
09/03/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/3/2020. To help expand the availability of medical gloves, the FDA is providing regulatory flexibility, as described in the enforcement policy for gloves that is in effect during the COVID-19 public health emergency. The FDA is also providing regular updates about medical gloves, including the answers to frequently asked questions on this page. (Text)
09/03/2020 12:00 AM EDT
Source: United Kingdom Department of Health (DH). Published: 9/3/2020. This 32-page paper is provided in the context of existing guidance and higher education sector plans, and aims to supplement these by summarizing the latest evidence relating to SARS-CoV-2 transmission associated with the resumption of higher education activities from Autumn 2020, particularly the return of undergraduate and postgraduate students. (PDF)
09/02/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/2/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Bio-Speedy Direct RT-qPCR SARS-CoV-2. The Bio-Speedy Direct RT-qPCR SARS-CoV-2 is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
09/01/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/1/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Kaira 2019-nCoV Detection Kit. The Kaira 2019-nCoV Detection Kit is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
09/01/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/1/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the MobileDetect Bio BCC19 Test Kit. The MobileDetect Bio BCC19 Test Kit is authorized for use with certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
09/01/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 9/1/2020. This web page aims to provide critical COVID-19 information metrics by technical area that response leaders in non-U.S. settings can request to aid in informing COVID-19 response decisions. It includes a set of core metrics within 10 technical areas for response leaders to help monitor response progress and guide decision making. (Text)
08/24/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/24/2020. This web page provides an overview of available resources related to SARS-CoV-2 screening testing and testing using pooled samples. (Text)
08/21/2020 12:00 AM EDT
Source: American College of Emergency Physicians (ACEP). Published: 8/21/2020. This summit, held in July 2020, brought together leaders across the College to discuss the future of emergency medicine and pandemics in four main areas: people (workforce), patients, practice, and payment. (Video or Multimedia)
08/19/2020 12:00 AM EDT
Source: National Academies of Sciences, Engineering, and Medicine. Published: 8/19/2020. This one-hour, three-minute webinar discusses protecting building engineering and maintenance staff from COVID-19. While many people are working remotely, the staff who keep facilities functioning must generally be on-site to do their jobs - telework is not an option. (Video or Multimedia)
07/14/2020 12:00 AM EDT
Source: National Network of Libraries of Medicine Greater Midwest Region (NNLM GMR). Published: 7/14/2020. The speakers in this one-hour webinar discuss how the Kalamazoo Public Library took very proactive steps to educate staff on opioid use, stock anti-overdose at public desks, partner with social service agencies, and advocate for changes in the state laws. (Video or Multimedia)
06/01/2020 12:00 AM EDT
Source: Trinity College Dublin. Published: 6/2020. This Self-Completion Questionnaire (SCQ) was developed to collect information from participants of The Irish Longitudinal Study on Ageing (TILDA) on the experiences of community-dwelling older adults aged 58 years and older during the COVID-19 pandemic in the Republic Of Ireland. TILDA is a longitudinal cohort studies of community-dwelling older adults that began in 2009. A full description of TILDA and its program of research to date can be accessed at https://tilda.tcd.ie/. The survey was administered in June 2020 and data collection will conclude in September 2020. Questions Adapted From: The questionnaire includes items used in earlier rounds of TILDA and as such are largely harmonized with other aging cohort studies in the Health and Retirement Study (HRS) family of studies that include the English Longitudinal Study of Ageing (ELSA) and the Survey of Health, Ageing and Retirement in Europe (SHARE). Population: Adults only Length: 81 questions Time to Complete: 30 to 40 minutes Mode of Administration: Pen and Paper Administered by: Self Administered Language(s): English (PDF)
04/27/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/27/2020. This Letter to Health Care Providers refers specifically to potential shortages relating to surgeons' gloves and patient examination gloves. The conservation strategies for use by health care organizations and personnel are categorized for a range of needs and supply levels and are intended to assist health care organizations as they determine procedures during the COVID-19 pandemic. (Text)
10/01/2019 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 10/2019. This course covers basic measures for statistical reporting, reporting laboratory data for influenza surveillance, and reporting laboratory data for influenza surveillance: data display; and includes a Capstone exercise. (Video or Multimedia)
10/01/2019 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 10/2019. This course covers Overview of Influenza and Influenza Surveillance; Implementing Intensified National SARI Surveillance; Data Analysis: Using Tables and Graphs to Present Surveillance Data; and Organizing the Intensified National Surveillance System. It includes a Capstone exercise. (Video or Multimedia)
.png)
No hay comentarios:
Publicar un comentario